A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
Clinical trial NCT03723655 · COMPLETED
Trial details
- NCT number
- NCT03723655
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-27
- Primary completion
- 2026-01-16
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.